Australia & United Kingdom — National Health Service
8 shared events · Importance 3 · Last updated Jun 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Tech
Australia: Australia participated in the international OPTIMA trial, contributing to the global validation of the Prosigna test's effectiveness in breast cancer treatment.
United Kingdom — National Health Service: The United Kingdom — National Health Service is expected to benefit from the Prosigna test, potentially allowing over 5,000 patients annually to avoid chemotherapy, leading to more efficient resource use.
May 29, 2026 · 21 articles
Domestic
Australia: Australia is where Fuller was diagnosed and initially treated. It serves as the location of her diagnosis and surgery.
United Kingdom — National Health Service: The NHS is the UK's public healthcare system, which does not routinely fund hyperthermia for brain tumors. The event underscores gaps in NHS coverage for experimental treatments.
Jul 16, 2026 · 7 articles
Tech
Australia: Australia is the country where Helena Teede, a lead author of the paper, is based at Monash Health.
United Kingdom — National Health Service: The United Kingdom — National Health Service in England has been criticized for its delay in updating public-facing resources to reflect the new PMOS terminology, potentially causing confusion for patients and healthcare providers.
May 12, 2026 · 145 articles
Accidents
Australia: Australia is sending a plane to evacuate its citizens and those from nearby countries.
United Kingdom — National Health Service: The United Kingdom — National Health Service's High Consequence Infectious Diseases network is supporting individuals undergoing self-isolation in the United Kingdom.
May 07, 2026 · 368 articles
Tech
Australia: Australian researchers and The Australia Institute are involved in the trial.
United Kingdom — National Health Service: The NHS would need to approve the treatment for availability in the UK.
Aug 19, 2026 · 108 articles
Business
Australia: Australia is a region where Optellum's diagnostic support modules are commercially available and its VNC solution is TGA-approved.
United Kingdom — National Health Service: The United Kingdom — National Health Service is a partner of Optellum in the UK, supporting the implementation of AI and robot lung cancer pathways.
Jun 04, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Australia and United Kingdom — National Health Service interact across events, view sentiment trends, and discover connected entities.
Open Dashboard